Adamas Pharmaceuticals reported -21606000 in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 566.96M 2.12M
Acorda Therapeutics ACOR:US $ 164.48M 26.01M
Adamas Pharmaceuticals ADMS:US -21606000 17.57M
Aerie Pharmaceuticals AERI:US $ -72.88M 33.26M
Aptinyx Inc APTX:US $ 112.04M 18.71M
Biocryst Pharmaceuticals BCRX:US $ -147.04M 40.97M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
GlaxoSmithKline GSK:LN 15426M 49M
Glaxosmithkline GSK:US $ 15426M 49M
Gw Pharmaceuticals GWPH:US $ 736.37M 4.72M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Intra Cellular Therapies ITCI:US $ 486.76M 66.83M
Marinus Pharmaceuticals MRNS:US $ 78.49M 16.57M
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Novartis NOVN:VX SF 56771M 2729M
Omeros OMER:US $ -262697000 16.4M
Prothena PRTA:US $ 490.47M 202.26M
Revance Therapeutics RVNC:US $ 120.16M 66.07M
Teva Pharmaceutical TEVA:IT 10.47B 143M
Zogenix ZGNX:US $ 224.3M 48.56M